An accurate diagnosis does not ensure that a patient understands its implications or receives appropriate care. This critical narrative review draws on purposively selected literature studies on diagnostic labels, explanations of test results, nocebo effects and care after diagnostic revision. Terminology experiments show changes in perceived severity and stated preferences, often in hypothetical settings. Clinical effects on symptoms and healthcare use depend on the intervention, comparator and outcome; explanation is frequently combined with treatment changes. Nocebo experiments demonstrate possible symptom mechanisms, not the cause of an individual patient’s continuing symptoms. Studies of diagnostic follow-up identify a separate problem: accurate or revised findings may fail to inform subsequent care. The synthesis distinguishes evidence for changing understanding, relieving symptoms and completing appropriate clinical action. A documented misunderstanding or obsolete instruction can warrant correction while symptom assessment continues. Evaluation should measure accurate understanding, informed choices and care received, with symptoms assessed separately. Truthful disclosure and follow-up remain responsibilities even when symptom benefit is uncertain.

Background/Objectives: Perinatal asphyxia (PA) is a major cause of neonatal mortality and morbidity both in the short and in the long term. The identification of novel reliable biomarkers is essential in order to improve early diagnosis and allow for accurate prognostication of short- and long-term outcomes. The aim of the current study was to identify serum metabolites substantially affected by PA and resuscitation, using an experimental model in neonate piglets. Methods: A prospective, randomized experimental pilot animal study was conducted in 33 neonate Landrace/Large White female piglets, 1–4 days old. Following initial preparation and stabilization, the animals were allocated to three groups. Group A served as the control group while Group B and Group C piglets underwent asphyxia until severe bradycardia or hypotension occurred. Group C animals were subsequently resuscitated, and after return of spontaneous circulation (ROSC), they were stabilized and remained under further monitoring for 30 min. Blood samples for metabolic profiling were obtained at predefined timepoints as defined below. “Baseline” samples were taken from all animals after the initial stabilization; “asphyxia” sampling was performed at the time of hemodynamic compromise, while “final” sampling was performed 1 h after baseline in Group A animals and 30 min post-ROSC in Group C animals. The serum samples obtained were further analyzed using nuclear magnetic resonance (NMR) spectroscopy. Results: Distinct metabolic phenotypes were observed between the “baseline” state and asphyxia. Post-resuscitation and post-ROSC, the metabolic phenotype appeared to partially shift back to the “baseline” cluster but remained distinct from both of the other groups. The results were further processed using a structured biomarker discovery pipeline. Key metabolites that were found to significantly differentiate “baseline” and “asphyxia” states were lactate, succinate, lysine, fumarate, hypoxanthine and isoleucine (decrease) (p < 0.001). As far as the “baseline” against stabilization post-ROSC comparison is concerned, lactate, lysine, fumarate, hypoxanthine, succinate, acetate, alanine, glutamine, glutamate and choline differed significantly (p < 0.001). No metabolite survived False Discovery Rate correction and reached statistical significance in the direct “Asphyxia” versus “Resuscitation” comparison. Conclusions: This pilot study demonstrates that severe asphyxia in neonatal piglets is associated with a distinct serum metabolic signature, and several abnormalities remain detectable 30 min after ROSC, suggesting incomplete early metabolic recovery. The findings support the candidacy of lactate, succinate, fumarate, hypoxanthine and related metabolites for further assessment and validation as markers of acute hypoxic injury. Further investigation focused on these metabolites could also contribute to the elucidation of the involved pathophysiological mechanisms of PA and the development of novel therapeutic approaches.